Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole Gerald Holtmann*,

Slides:

Advertisements

Similar presentations

Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.

Advertisements

Volume 117, Issue 6, Pages (December 1999)

Follow-up Testing After Treatment of Helicobacter Pylori Infections: Cautions, Caveats, and Recommendations Taraq A. Attumi, MD, David Y. Graham, MD

It's time to bring the best and brightest back to gastroenterology!

Opened Proton Pump Inhibitor Capsules Reduce Time to Healing Compared With Intact Capsules for Marginal Ulceration Following Roux-en-Y Gastric Bypass

Helicobacter pylori infection and gastric carcinoma

Low prevalence of Helicobacteraceae in gall-stone disease and gall-bladder carcinoma in the German population U.R.M. Bohr, D. Kuester, F. Meyer, T. Wex,

An Efficacious and Cost-Effective Pharmacologic Treatment for Helicobacter pylori Sarah Gurney, MSN, FNP, Laura Carvalho, MSN, FNP, Carrie Gonzalez, MSN,

Metronidazole susceptibility in Helicobacter pylori

An Efficacious and Cost-Effective Pharmacologic Treatment for Helicobacter pylori Sarah Gurney, MSN, FNP, Laura Carvalho, MSN, FNP, Carrie Gonzalez, MSN,

Volume 114, Issue 3, Pages (March 1998)

L. Boyanova Clinical Microbiology and Infection

Complications of Proton Pump Inhibitor Therapy

Volume 119, Issue 3, Pages (September 2000)

Helicobacter pylori infection and gastric carcinoma

First successful treatment of a primary high-grade gastric MALT lymphoma by eradication therapy for Helicobacter pylori Stephan Timm, Marco Sailer, Karl–hermann.

Diagnosis of irritable bowel syndrome

Diagnosis of celiac sprue

Volume 116, Issue 2, Pages (February 1999)

Low prevalence of Helicobacteraceae in gall-stone disease and gall-bladder carcinoma in the German population U.R.M. Bohr, D. Kuester, F. Meyer, T. Wex,

Functional Gastroduodenal Disorders

Gastric cancer, cytotoxin-associated gene A–positive Helicobacter pylori, and serum pepsinogens: An international study Penelope M. Webb, Jean E. Crabtree,

CHUNG H. KIM, M.D., MICHAEL G. SARR, M.D. Mayo Clinic Proceedings

Psychiatric disorders among veterans with hepatitis C infection

Covering the Cover Gastroenterology

Volume 118, Issue 5, Pages (May 2000)

Benjamin C.Y. Wong, Yoshikazu Kinoshita

Volume 124, Issue 4, Pages (April 2003)

PPI-based triple therapy in the eradication of H. pylori infection

An Efficacious and Cost-Effective Pharmacologic Treatment for Helicobacter pylori Sarah Gurney, MSN, FNP, Laura Carvalho, MSN, FNP, Carrie Gonzalez, MSN,

Volume 114, Issue 3, Pages (March 1998)

Metronidazole susceptibility in Helicobacter pylori

Follow-up Testing After Treatment of Helicobacter Pylori Infections: Cautions, Caveats, and Recommendations Taraq A. Attumi, MD, David Y. Graham, MD

Volume 129, Issue 6, Pages (December 2005)

Volume 115, Issue 1, Pages (July 1998)

Hepatitis B infection in heart transplant recipients

Volume 123, Issue 2, Pages (August 2002)

Volume 119, Issue 1, Pages 7-14 (July 2000)

Management of Patients With Functional Heartburn

Genetics of Colonic Polyposis

Volume 130, Issue 6, Pages (May 2006)

Ikuo Hirano, Qing Zhang, John E. Pandolfino, Peter J. Kahrilas

Effectiveness of proton pump inhibitors in nonerosive reflux disease

Many Patients Continue Using Proton Pump Inhibitors After Negative Results From Tests for Reflux Disease Andrew J. Gawron, Jami Rothe, Angela J. Fought,

Severe Constipation Clinical Gastroenterology and Hepatology

Angela Wong, Rebecca C. Fitzgerald

Volume 116, Issue 2, Pages (February 1999)

Volume 118, Issue 4, Pages (April 2000)

Volume 139, Issue 2, Pages (August 2010)

Volume 121, Issue 4, Pages (October 2001)

Effect of antioxidants on the immune response of Helicobacter pylori

Barry Marshall 2005 Nobel Laureate in Medicine and Physiology

Peter Bytzer Clinical Gastroenterology and Hepatology

Volume 117, Issue 6, Pages (December 1999)

Regression of MALT lymphoma of the rectum after anti–H

Systematic Review: Patterns of Proton Pump Inhibitor Use and Adherence in Gastroesophageal Reflux Disease A. Pali S. Hungin, Catherine Hill, Michael.

Volume 117, Issue 1, Pages (July 1999)

Psychiatric disorders among veterans with hepatitis C infection

Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole Gerald Holtmann*,

The Toronto Helicobacter pylori Consensus in Context

Esophageal variceal bleeding: Primary prophylaxis

Volume 121, Issue 5, Pages (November 2001)

Issue Highlights Clinical Gastroenterology and Hepatology

Endoscopic diagnosis and treatment of gastric bezoars

Volume 156, Issue 5, Pages (April 2019)

Michelle Maria Pietzak Gastroenterology

Eradication Therapy for Helicobacter pylori

Scott K. Fung, Anna S.F. Lok Clinical Gastroenterology and Hepatology

Rintaro Hashimoto, Akimichi Chonan

Rintaro Hashimoto, Akimichi Chonan

Presentation transcript:

Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole Gerald Holtmann*, Clive Cain‡, Peter Malfertheiner§ Gastroenterology Volume 117, Issue 1, Pages 11-16 (July 1999) DOI: 10.1016/S0016-5085(99)70544-5 Copyright © 1999 American Gastroenterological Association Terms and Conditions

Fig. 1 Healing rates (%) at (A) 4 and (B) 8 weeks and 95% CI for H. pylori–positive and –negative patients (Cochran–Mantel–Haenszel test, one-sided, α = 0.025). Gastroenterology 1999 117, 11-16DOI: (10.1016/S0016-5085(99)70544-5) Copyright © 1999 American Gastroenterological Association Terms and Conditions